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SUMMARY
Interactions between the host and its microbiota are
of mutual benefit and promote health. Complex mo-
lecular pathways underlie this dialog, but the identity
of microbe-derived molecules that mediate the
mutualistic state remains elusive.Helicobacter hepa-
ticus is a member of the mouse intestinal microbiota
that is tolerated by the host. In the absence of an
intact IL-10 signaling, H. hepaticus induces an
IL-23-driven inflammatory response in the intestine.
Here we investigate the interactions between
H. hepaticus and host immune cells that may pro-
mote mutualism, and the microbe-derived mole-
cule(s) involved. Our results show that H. hepaticus
triggers early IL-10 induction in intestinal macro-
phages and produces a large soluble polysaccharide
that activates a specific MSK/CREB-dependent anti-
inflammatory and repair gene signature via the re-
ceptor TLR2. These data identify a host-bacterial
interaction that promotes mutualistic mechanisms
at the intestinal interface. Further understanding of
this pathwaymay provide novel prevention and treat-
ment strategies for inflammatory bowel disease.
INTRODUCTION
Shaped by a long history of co-evolution, the relationship be-
tween mammalian hosts and their intestinal commensal bacteria
is of mutual benefit and promotes health. Complex molecular
pathways underlie this dialog; however, the identity of microbe-
derived molecules that contribute to the mutualistic state remain
elusive. In inflammatory bowel disease (IBD), maladaptation of
the host-microbe interface results in aberrant inflammatory re-
sponses to the intestinal microbiota. Recent evidence suggests
that a complex interplay of host genetic, environmental, and mi-
crobial factors contributes to disease development (Kaser et al.,
2010). Studies both in mousemodels and in human disease have
highlighted the role of appropriate intestinal epithelial barrier
function, host defense, and immune regulation formaintaining in-
testinal homeostasis (Maloy and Powrie, 2011).
Infection of mice with the mouse pathogen Helicobacter hep-
aticus has provided important insights into host-microbe interac-
tions in the gut. H. hepaticus inhabits the lower intestine, primar-
ily the caecum, but does not induce immune pathology in normal
mice (Kullberg et al., 1998). However, infection of genetically
susceptible T and B cell-deficient 129SvEvRag/ mice results
in colitis (Erdman et al., 2003; Maloy et al., 2003), and
H. hepaticus exacerbates T cell transfer colitis in C.B17 severe
combined immunodeficient mice (Cahill et al., 1997). Appro-
priate host immune regulatory responses are crucial, as
H. hepaticus infection of lymphocyte-replete mice with genetic-
or pharmacological-induced deficiencies of the interleukin-10/
interleukin-10 receptor (IL-10/IL-10R) pathway also results in co-
litis and typhlitis (Kullberg et al., 1998, 2006; Morrison et al.,
2013). Under these circumstances, there is an aberrant IL-23-
driven inflammatory response in the intestine with accumulation
of pro-inflammatory granulocytes and monocytes that contrib-
utes to disease pathology (Arnold et al., 2016; Griseri et al.,
2012; Hue et al., 2006; Krausgruber et al., 2016). Early studies
showed that infection with H. hepaticus induces colonic regula-
tory T cells that prevent inflammation in an IL-10-dependent
manner (Kullberg et al., 2002) and, more recently, that large
amounts of IL-23 impede this response (Schiering et al., 2014).
Relying both on a bacterial trigger and on an immune defect,
H. hepaticus-induced colitis in the presence of IL-10/IL-10R
pathway deficiency shares many features of human IBD. Indeed,
mutations in Il10 or Il10R result in severe early-onset forms of IBD
(Glocker et al., 2009; Kotlarz et al., 2012; Uhlig et al., 2014),
indicating that IL-10 signaling is critical to prevent colitis both
in humans and in mice. To date, little is known about the interac-
tion ofH. hepaticuswith the innate immune compartment and its
capacity to induce IL-10 production by these cells.
Strategically located at the mucosal barrier, intestinal lamina
propria-resident macrophages function as immune sentinels.
Essential for maintaining homeostatic responses, they are
both sensors and interpreters of the intestinal tissue
Cell Host & Microbe 22, 733–745, December 13, 2017 ª 2017 The Author(s). Published by Elsevier Inc. 733
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
microenvironment, which comprises microbes and their prod-
ucts, and of immune mediators such as cytokines and chemo-
kines (Ginhoux et al., 2016). The loss of IL-10R in tissue-resident
macrophages results in spontaneous colitis, highlighting the
importance of the macrophage response to IL-10 (Zigmond
et al., 2014).Microbial products fromboth commensals and path-
ogens are recognized by pattern recognition receptors (PRRs),
including Toll-like receptors (TLRs). The activation of PRRs trig-
gers the production of pro-inflammatory mediators, such as IL-
6 and tumor necrosis factor-a (TNFa), via several signaling path-
ways including the transcription factor NF-kB (Cohen, 2014). To
prevent chronic inflammation and tissue damage, PRRs also acti-
vate anti-inflammatory signals, such as IL-10, together with nega-
tive feedback mechanisms, including the transcriptional
repressor cAMP response element-binding protein (CREB)
(Wen et al., 2010). However, the signalingmechanisms employed
by particular gut inhabitants to actively promote intestinal homeo-
stasis are poorly understood, as is their interaction with intestinal
macrophages.
Here, we have investigated the interactions between
H. hepaticus and macrophages that may promote tolerance
and mutualism. Our results show that H. hepaticus induces an
early IL-10 response by intestinal macrophages and produces
a large soluble polysaccharide that activates a specific MSK/
CREB-dependent anti-inflammatory and repair gene signature
via the receptor TLR2.
RESULTS
H. hepaticus Induces IL-10 in Gut-Resident
Macrophages
As blockade of IL-10 signaling induces colitis in mice colo-
nized with H. hepaticus (Kullberg et al., 2006; Morrison
et al., 2013), we first assessed whether H. hepaticus interacts
directly with the innate immune compartment within the intes-
tinal mucosa to trigger IL-10 production. In order to investi-
gate early responses to H. hepaticus at the cellular level, lam-
ina propria leukocytes (LPL) from the colonic and caecal
mucosa were isolated from Specific Pathogen Free (SPF)
mice 3 days after infection with H. hepaticus strain
ATCC51449 (Figure 1A). Flow cytometric analysis revealed
that the frequency of CD4+ IL-10high T cells did not change
at this time point (Figure S1A). Similarly, the frequency of
MHCII+CD11b+CD11cint/highCD64+ resident macrophages
Figure 1. H. hepaticus Induces IL-10 in Gut-Resident Macrophages
(A–D) SPF WT mice were infected with Helicobacter hepaticus (Hh) for 3 or 5 days.
(A) Experimental design.
(B and C) FACS analysis of caecum and colon LPL after 3 days of infection with Hh. (B) Frequency of resident macrophages among total CD45+ cells.
(C) Frequency of IL-10high cells among resident macrophages, using an anti-mouse IL-10 antibody or its isotype control.
(D) Expression level of Il10, Il6, and Tnf mRNA in caecum or colon tissue after 3 or 5 days of infection with Hh.
Each symbol represents an individual mouse (two to three independent experiments). Mann-Whitney test (B and C) or one-way ANOVA and Tukey’s multiple
comparisons test (D), p < 0.05. See also Figure S1.
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among total CD45+ cells was unaffected by H. hepaticus
infection (Figure 1B). However, the percentage of IL-10high
resident macrophages increased significantly in the caecum
following H. hepaticus colonization (Figures 1C and S1B). In
whole tissue, no difference in levels of Il10mRNA could be de-
tected 3 days following infection (Figure 1D). However, there
was a marked increase in the amount of Il10 mRNA 5 days af-
ter infection in both caecum and colon, whereas mRNA levels
of the pro-inflammatory cytokines IL-6 and TNFa were un-
changed or moderately increased, respectively (Figure 1D).
These data indicate that H. hepaticus selectively promotes
IL-10 production without a corresponding increase in pro-in-
flammatory cytokines from intestinal macrophages.
H. hepaticus Produces a Large Soluble Polysaccharide
that Can Induce IL-10 Production by Macrophages
To investigate whether H. hepaticus directly induces IL-10 in
macrophages, we generated M-CSF differentiated bone
marrow-derived macrophages (BMDMs) and subjected them
to stimulation with whole bacteria (Hh, strain ATCC51449), a
filtered supernatant of H. hepaticus culture medium (SNHh)
or the control culture medium (TSB). Measurement of cytokine
gene transcription and protein expression after 3 hr stimulation
showed that Hh induced high amounts of IL-10 and moderate
IL-6 and TNFa (Figures 2A and S2A). Interestingly, SNHh was
sufficient to induce equivalent amounts of IL-10 in BMDMs,
but a markedly diminished amount of IL-6 and TNFa
Figure 2. H. hepaticus Produces a Large Soluble Polysaccharide-Inducing IL-10 Production in Macrophages
(A–G) M-CSF-differentiated BMDMs were stimulated for 3 hr with different culture fractions of H. hepaticus.
(A) mRNA and protein induction of the cytokines IL-10 and IL-6 after stimulation with control medium (TSB), H. hepaticus whole bacteria (Hh), or H. hepaticus-
filtered cultured supernatant (SNHh).
(B–D) Induction of (B) IL-10, (C) IL-6, and (D) IL-10/IL-6 ratio after 3 hr stimulation with SNHh treated with enzymes and heat (SNHht), SNHht fractionated by size
(SNHht > 30 kDa and SNHht < 30 kDa), and LPS UP.
(E) Induction of IL-10 after stimulation with TSBt or SNHht, treated with buffer () or sodiummetaperiodate (+, NaIO4). Stimulation with TSBt ± NaIO4 and LPS ST
is used as a positive control for IL-10 production by BMDMs.
(F) Induction of IL-10 after stimulation with TSBt, LPS ST, SNHht, or SNHht depleted using increasing concentrations of ConA-lectin beads (0.8%, 1.5%, 3%, and
6% v/v).
(G) Induction of IL-10 and IL-6 after stimulation with SNHht crude polysaccharide fraction extracted by a cold-ethanol precipitation method (CPHht).
Data from three independent experiments. Mann-Whitney test, p < 0.05. Mean ± SD. LPS UP, LPS ultrapure from E. coli O111:B4; LPS ST, LPS standard from
E. coli O55:B5. See also Figure S2.
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compared to whole bacteria (Figures 2A and S2A). Treatment
of SNHh (SNHht) with DNase, RNase, and proteinase K fol-
lowed by heat (2 hr, 95C) had no effect on its capacity to
induce IL-10 production in BMDMs, but significantly attenu-
ated both IL-6 and TNFa production (Figures 2B, 2C, S2B,
and S2C). This suggests that the IL-10-inducing factor pro-
duced by H. hepaticus is not a nucleic acid or a protein, and
therefore likely a polysaccharide. Fractionation by size using
Vivaspin concentrator columns showed that the ability to
induce IL-10 in BMDMs was restricted to a high molecular
weight component (SNHht > 30 kDa), indicating that the active
molecule is a large polysaccharide (Figure 2B). Stimulation
with SNHht and SNHht > 30 kDa resulted in significantly higher
IL-10/IL-6 and IL-10/TNFa ratios compared to whole
H. hepaticus and non-treated SNHh (Figures 2D and S2C).
Comparison with a known bacteria-derived immunostimula-
tory ligand, ultra-pure lipopolysaccharide from Escherichia
coli (LPS UP), showed that the latter produced a more mixed
cytokine response with large amounts of IL-10, IL-6, and
TNFa, resulting in lower IL-10/IL-6 and IL-10/TNFa ratios
compared to SNHht (Figures 2B–2D and S2C). SNHht induced
IL-10 in a dose-dependent manner, but the IL-10/IL-6 and
IL-10/TNFa ratios remained constant (Figure S2D). This
suggests that the high ratios induced by SNHht are not a
function of the stimulus concentration and reflect a qualitative
response.
To further characterize the active molecule released into
H. hepaticus culture supernatant that differentially stimulates
IL-10 production, we oxidized SNHht using sodium metaperio-
date (NaIO4) and dialyzed it against water to remove traces of
reagent. This treatment cleaves sugars in the polysaccharide
chains. Strikingly, after NaIO4 oxidation, SNHht lost its capac-
ity to induce IL-10 (Figure 2E), supporting the idea that the
active molecule in SNHht is a polysaccharide. This result was
not a consequence of cellular toxicity of residual NaIO4 as
simultaneous stimulation with both TSBt treated with NaIO4
and standard E. coli LPS (LPS ST) triggered IL-10 production
by BMDMs (Figure 2E). To complement this approach, we sub-
jected SNHht to incubation with different lectin-coated
agarose beads. Lectins are carbohydrate-binding proteins
with high specificity for mono- and oligosaccharides that also
bind a diversity of complex polysaccharides. Our results
showed that Concanavalin A from Canavalia ensiformis
(ConA)-coated beads could deplete the IL-10-inducing factor
from SNHht in a dose-dependent manner (Figure 2F), whereas
other lectin-coated beads (lectins from Arachis hypogea, Pea-
nut Agglutinin (PNA) or Lens Culinaris (LcH) had little effect on
SNHht-induced IL-10 (Figure S2E). The lectins did not directly
affect the capacity of BMDMs to produce IL-10, as shown by
the simultaneous stimulation with both TSBt treated with
ConA-coated beads and LPS ST (Figure 2F). Depletion by
ConA suggests that SNHht is rich in a-mannose and a-glucose
sugars. Finally, we used cold-ethanol precipitation to isolate
the crude polysaccharide fraction (CPHht) from the treated su-
pernatant (SNHht). CPHht recapitulated SNHht activity on
BMDMs, with induction of high IL-10 but low IL-6 production
(Figures 2G and S2B).
Collectively, these data indicate that H. hepaticus releases a
large polysaccharide into the culture medium that induces mac-
rophages to produce a selective response with large amounts of
IL-10 and smaller amounts of pro-inflammatory cytokines such
as IL-6 and TNFa.
H. hepaticus Supernatant Is Sufficient to Induce IL-10
In Vivo
To assess the activity of H. hepaticus polysaccharide in vivo, we
orally administered TSBt, SNHht, or live H. hepaticus to SPF
mice daily for 2 days and analyzed the colon and caecum LPL
by flow cytometry on day 3. LikeH. hepaticus infection (Figure 1),
SNHht treatment similarly increased the frequency of IL-10high
intestinal macrophages in the caecum, but not in the colon (Fig-
ures 3A, S3A, and S3B).
To test the activity of SNHht in a different immune compart-
ment, we injected TSBt or SNHht intraperitoneally either daily
for 2 days with analysis 48 hr after the first administration or
as a single injection with analysis after 6 hr. In both conditions,
SNHht induced a significant increase in Il10 mRNA in total
peritoneal cells compared to TSBt controls, with no change
in Il6 or Tnf (Figures 3B, 3C, and S3C), similar to the in vitro
observations. Pam3CSK4 (Pam3) and LPS UP injections
induced similar Il10mRNA but higher amounts of Il6 (Figure 3C)
and Tnf (non-significant; Figure S3C) in total peritoneal cells
after 6 hr.
SNHht Signals through TLR2 and MyD88 to Induce IL-10
To determine which sensing pathways were used by macro-
phages for IL-10 induction, we stimulated a panel of knockout
BMDMs deficient in signaling proteins or PRRs—such as TLRs,
NOD-like receptors (NLRs), and C-type lectin receptors
(CLRs)—with SNHht or TSBt. In the response to bacterial
components, TLR activation leads to recruitment of the adaptor
molecules MyD88 (myeloid differentiation primary response
gene 88) and/or TRIF (Toll-interleukin receptor domain contain-
ing adaptor-inducing interferon-g), and switches on signaling
networks that induce the production of various cytokines
including IL-10, IL-6 and TNFa. Interestingly, Myd88/ and
Myd88/Trif/, but not Trif/ BMDMs, lost their capacity
to induce IL-10 at both transcriptional and protein levels in
response to a 3 hr stimulation with SNHht (Figures 4A
and 4B). Among the TLR-deficient cells tested (Tlr1/, Tlr2/,
Tlr3/, Tlr4/, Tlr6/, and Tlr9/), only Tlr2/ BMDMs
failed to produce IL-10 after stimulation with SNHht
(Figures 4A and 4B), suggesting that SNHht signals through
the TLR2/MyD88 pathway. As expected, the crude polysaccha-
ride fraction CPHht and the canonical TLR2/1 ligand Pam3
were not able to induce IL-10 in Tlr2/ BMDMs, contrary to
the TLR4 ligand LPS UP (Figure 4C). By contrast, BMDMs defi-
cient for CLRs (MINCLE, CLEC4E; DECTIN-1, CLEC7A; MCL,
CLECSF8; DNGR1, CLEC9A; MICL, CLEC12A), other receptors
(IFNAR, interferon-a/b receptor; MR, Mannose Receptor; SRA,
Scavenger Receptor A; MARCO; NOD2) or signaling proteins
(RIP2; CARD9) were still able to produce IL-10 after stimulation
with SNHht (Figure 4A).
As a complementary approach, a TLR2 blocking monoclonal
antibody or an isotype control was added prior to BMDM stim-
ulation with SNHht or different canonical TLR ligands. TLR2
blockade inhibited IL-10 induction by SNHht and Pam3
(TLR2/1 ligand) but not by Pam2CSK4 (Pam2, TLR2/6) or
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LPS UP (TLR4) (Figure 4D). Downstream of TLR2 and MyD88,
the mitogen-activated protein kinase (MAPK) TAK1 acts as an
activator of several kinases, including the MAPKs ERK1/2, p38,
and c-jun N-terminal kinase (JNK), which converge on tran-
scription factors such as NF-kB. Pharmacological blockade
of these downstream kinases showed that IL-10 induction by
SNHht involves TAK1, MEK1/2 (ERK pathway), and p38, with
comparatively weak contributions by JNK and NF-kB (Fig-
ure S4A). Immunoblot analysis showed marked phosphoryla-
tion of ERK1/2 (pT202/Y204) and p38 (pT180/Y182) MAPKs
in WT BMDMs stimulated with SNHht at early time points
(15 and 30 min) compared to Pam3 and LPS UP, with no
change in total protein amounts (Figure 4E). As expected, the
phosphorylation pattern induced by SNHht and Pam3 was
lost in Tlr2/ BMDMs (Figure 4E). In addition, as SNHht
signals through TLR2, we compared its capacity to induce
IL-10, IL-6, and TNFa in BMDMs to various canonical TLR2
and TLR4 ligands. Interestingly, SNHht induced higher IL-10/
IL-6 and IL-10/TNFa ratios compared to Pam2 (TLR2/6 ligand),
Pam3 (TLR2/1), FSL-1 (TLR2/6), zymosan from Saccharo-
myces cerevisiae (TLR2), lipomannan from Mycobacterium
smegmatis (TLR2), LPS UP (TLR4), and LPS ST (TLR4 and
TLR2) (Figure S4B).
These data indicate that TLR2/MyD88 is the pathway required
for SNHht signaling, and furthermore that SNHht is a stronger
driver of anti-inflammatory activity in macrophages than canon-
ical TLR2 agonists.
Differential Regulation of Transcription by SNHht
and Pam3
In order to assess whole genome differences in the macrophage
transcriptional response to SNHht or to the canonical TLR2/1
agonist Pam3, we performed a microarray analysis of TSBt,
SNHht, or Pam3-stimulated M-CSF differentiated BMDMs. Prin-
ciple components analysis (PCA) demonstrated clear gene
expression differences in macrophages stimulated by SNHht
compared to Pam3 (Figure 5A). Hierarchical clustering analysis
of differentially regulated genes identified four distinct clusters
of co-regulated genes (Figure 5B). Each gene was assigned to
a distinct cluster using k-means clustering (k = 4), representing
genes that were (1) induced by Pam3 only (red cluster 1,
n = 75); (2) repressed by both SNHht and Pam3 (green cluster
2, n = 10); (3) induced by both SNHht and Pam3 (blue cluster
3, n = 68); and (4) induced by SNHht only (purple cluster 4,
n = 19). A large repertoire of pro-inflammatory genes was asso-
ciated with the Pam3-specific transcriptional signature (Fig-
ure 5C). These included a number of genes associated with
M1 pro-inflammatory macrophages (Il6, Saa3, Ccl5, Lcn2, and
Fpr2) and others involved in the recruitment, activation, and pro-
liferation of T cells (Cd40 or Tnfrsf5, Tnfrsf9, Icam1) (Chen and
Flies, 2013; Lebedeva et al., 2005; Liu et al., 2013; Zigmond
et al., 2014). By contrast, SNHht specifically induced the tran-
scription of a number of genes that are highly expressed in tissue
resident or M2 macrophages (Ccl7, Mmp13, Ptpn22) (Chang
et al., 2013; Shi and Pamer, 2011; Toriseva et al., 2012),
Figure 3. SNHht Is Sufficient to Induce IL-10 In Vivo
(A) Frequency of IL-10high cells among resident macrophages from caecum and colon LPL. SPF WT mice were infected with Hh or orally gavaged with TSBt or
SNHht for 3 days.
(B and C) Il10, Il6, and Tnf mRNA expression levels in the peritoneal cell fraction after 2 days (B) or Il10 and Il6 mRNA transcripts after 6 hr (C) challenge.
Ligands (TSBt and SNHht, 200 mL; LPS UP and Pam3, 50 mg) were injected into the intraperitoneal cavity of SPFWT mice. Each symbol represents an individual
mouse (two to three independent experiments). Pam3, Pam3CSK4. Mann-Whitney test, p < 0.05. See also Figure S3.
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transcription factors known to repress the NF-kB pathway
(Rcan1, Atf3) and T cell activation (Egr3), and genes involved in
tissue repair and wound healing (Edn1, Mmp13, Hbegf) (Fig-
ure 5C) (Cheluvappa et al., 2014; De Nardo et al., 2014; Junkins
et al., 2013; Safford et al., 2005; Toriseva et al., 2012; Wei et al.,
2015). Of note, we observed that although the anti-inflammatory
cytokine IL-10 was induced by both SNHht and Pam3
(compared to TSBt), the strength of induction was greater for
SNHht, consistent with a lower capacity to induce a pro-inflam-
matory response upon SNHht stimulation (Figure 5C).
We reasoned that the differential transcriptional programs
activated in response to these two TLR2 agonists were driven
by alternative transcription factor profiles. To test this, we per-
formed enrichment analysis of transcription factor motif gene
sets from the Molecular Signatures Database (MSigDB) among
genes that were specifically induced by either SNHht (purple
cluster 4) or Pam3 (red cluster 1). Specific targets induced by
SNHht were enriched for genes (Rcan1, Egr3, Fosb) with pre-
dicted binding sites for multiple transcription factors that
included two motifs for the cyclic AMP response-element bind-
ing protein (CREB) (Figure 5D). This is of interest as CREB is a
key transcriptional regulator known to promote anti-inflamma-
tory signaling and repair (Lawrence and Natoli, 2011; Wen
et al., 2010). Therefore, CREB activation might play a role in
the suppression of TLR2-induced pro-inflammatory responses
by SNHht. In addition, the observation of a more pro-inflamma-
tory transcriptional program in response to Pam3 was confirmed
through the identification of a significant enrichment of genes
Figure 4. SNHht Signals through TLR2 and MyD88 to Induce IL-10
(A) Induction of IL-10 production in different knockout C57BL/6 BMDMs stimulated for 3 hr with SNHht normalized to WT BMDMs (three independent experi-
ments). Two-way ANOVA and Bonferroni’s multiple comparisons test, p < 0.05. Ifnar, interferon-a/b receptor;Mr, mannose receptor; Sra, scavenger receptor A.
(B) Il10mRNA and protein induction in different knockout BMDMs stimulated for 3 hr with SNHht (one of three independent experiments). One-way ANOVA and
Tukey’s multiple comparisons test, p < 0.05.
(C) Induction of IL-10 production in WT and Tlr2/ BMDMs stimulated for 3 hr with TSBt, SNHht, CPHht (SNHht crude polysaccharide fraction), LPS UP (TLR4
ligand), or Pam3 (TLR2/1) (one of three independent experiments). Two-way ANOVA and Sidak’s multiple comparisons test, p < 0.05.
(D) Induction of IL-10 production in WT BMDMs pre-treated for 2 hr with a blocking antibody specifically inhibiting TLR2 signaling (monoclonal a-mTLR2-IgG) or
its isotype control before stimulation for 3 hr with TSBt, SNHht, Pam2 (TLR2/6), Pam3, or LPS UP (three independent experiments). Two-way ANOVA and Sidak’s
multiple comparisons test, p < 0.05.
(E) Western blot showing the phosphorylation of ERK1/2 and p38 and the total ERK1/2 and p38 protein amounts in WT and Tlr2/ BMDMs after stimulation with
TSBt, SNHht, Pam3, or LPS UP for 15 min, 30 min, and 3 hr. Mean ± SD. See also Figure S4.
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with predicted NF-kB binding sites among genes that were spe-
cifically induced by Pam3 stimulation (Figure 5E). Differential in-
duction of each gene of interest, including targets of CREB (Il10,
Fosb, Egr3, Rcan1) and NF-kB (Il6,Ccl5,Cd40, Icam1), was vali-
dated by qRT-PCR (Figure 5F).
Taken together, these data suggest that TLR2 activation in
BMDMs results in markedly different transcriptional programs
depending on the agonist. The increased anti-inflammatory
properties of SNHht are likely dependent on its ability to activate
CREB and repress the pro-inflammatory cytokine response.
SNHht Stimulates CREB Phosphorylation and Induction
of an Anti-inflammatory and Repair Gene Signature in
Macrophages
Immunoblot analysis of pS133-CREB1 and pS536-RelA in
BMDMs revealed differential induction of CREB and NF-kB
Figure 5. Differential Regulation of Transcription by SNHht and Pam3
(A–F) Microarray analysis performed on M-CSF BMDMs differentiated from 5 WT mice and stimulated for 3 hr.
(A) Principle components analysis (PCA) of transcriptional profiles (empirical Bayes normalized expression values from LIMMA) across three conditions (TSBt,
Pam3, and SNHht, n = 5/condition, 16,692 probes).
(B) Hierarchical clustering heatmap (Manhattan distance with Ward clustering of empirical Bayes normalized expression values) of the union of differentially
expressed probes between any condition-condition contrast (i.e., TSBt versus Pam3, TSBt versus SNHht, or Pam3 versus SNHht) (n = 172 probes, n = 146
genes). Probes were assigned to clusters using k-means clustering (k = 4) and cluster assignments are annotated as colors to the left of the heatmap. The number
of probes assigned to each cluster were: cluster 1 = 75, cluster 2 = 10, cluster 3 = 68, and cluster 4 = 19.
(C) Scatterplot displaying the relationship between log2 (fold changes) for each gene shown in (B) obtained when comparing either Pam3 (x axis) or SNHht (y axis)
with the TSBt control condition. Colors represent the cluster assignments.
(D and E) Transcription factor (TF) motif enrichment analysis among genes assigned to (D) cluster 4 (i.e., specifically induced by SNHht) and (D) cluster 1 (i.e.,
specifically induced by Pam3). Motif names correspond to Transfac motif identifiers derived from the Molecular Signatures Database (MSigDB). Motifs signif-
icantly overrepresented at an adjusted p < 0.05 (permutation test) are shown.
(F) mRNA levels of CREB (Il10, Fosb, Egr3, Rcan1) and NF-kB (Il6, Ccl5, Cd40, Icam1) target genes were validated by qRT-PCR.
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pathways after 30 min stimulation with SNHht, Pam3, or LPS UP
(Figure 6A). Consistent with the microarray data, SNHht induced
stronger CREB but weaker RelA phosphorylation compared to
Pam3, and this pattern was lost in Tlr2/ cells (Figure 6A). To
test the functional role of CREBS133 phosphorylation in the induc-
tion of the CREB target genes identified in Figure 5, we differen-
tiated BMDMs from conditional CREBS133A KI (Serin replaced by
Alanin in position 133 of the CREB protein) and CREBWT mice.
These mice were both generated using a minigene strategy
(Wingate et al., 2009) with a CRE recombinase under the vav pro-
moter, expressed throughout the hematopoietic compartment.
CREB could not be phosphorylated at Ser133 in conditional
Vav-cre CREBS133A KI BMDMs after stimulation with SNHht (Fig-
ure S5A). Stimulation of conditional Vav-cre CREBS133A KI and
CREBWT BMDMs with SNHht for 1 hr showed significant induc-
tion of the CREB target genes Il10, Fosb, and Egr3 relative to
stimulation with whole H. hepaticus or Pam3 (Figure 6B). The in-
duction of Il10, Fosb, and Egr3was partially dependent on CREB
phosphorylation, whereas Il6, Tnf, or Cd40 induction was unaf-
fected (Figures 6B and S5B). Antibody blockade of the IL-10R
showed that induction of CREB target genes, specifically Fosb,
Egr3, and Rcan1, was not due to an IL-10 autocrine pathway
(Figure S5C). Interestingly, after 10 hr stimulation, CREBS133A KI
BMDMs produced less IL-10 but more IL-6 and TNFa in
Figure 6. SNHht Stimulates CREB Phosphorylation and Induction of an Anti-inflammatory and Repair Gene Signature in Macrophages
(A) Western blot showing the phosphorylation of CREB1 S133 and RelA S536 and the total CREB1 and RelA protein amounts in WT and Tlr2/ BMDMs after
30 min stimulation with TSBt, SNHht, Pam3, or LPS UP. b-actin used as a loading control.
(B) mRNA levels of Il10, Fosb, and Egr3 genes in BMDMs from conditional vav-cre CREBWT and CREBS133A KI mice after 1 hr stimulation with TSBt, Hh, SNHht,
or Pam3.
(C) Induction of IL-10, IL-6, and TNFa; IL-10/IL-6; and IL-10/TNFa protein ratios in BMDMs from conditional vav-cre CREBWT and CREBS133A KI mice after 10 hr
stimulation with TSBt, Hh, SNHht, or Pam3. One of three independent experiments. Two-way ANOVA and Sidak’s and/or Tukey’s multiple comparisons tests,
p < 0.05.
(D) mRNA levels of Il10, Fosb, Egr3, Rcan1, Il6, Tnf, and Cd40 genes in caecum total tissue from WT mice gavaged with TSBt or SNHht for 2 days. Each symbol
represents an individual mouse (two independent experiments). Mann-Whitney test, p < 0.05.
Mean ± SD. See also Figure S5.
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response to SNHht compared to CREBWT BMDMs (Figure 6C).
This led to strongly reduced IL-10/IL-6 and IL-10/TNFa ratios,
reaching levels similar to those observed with whole
H. hepaticus or Pam3 (Figure 6C). Importantly, the induction of
anti-inflammatory CREB targets (Fosb, Egr3, Rcan1) but not
pro-inflammatory NF-kB targets (Il6, Tnf, Cd40) was also
observed in total caecum tissue from mice gavaged for 2 days
with SNHht (Figure 6D). These data indicate that CREB phos-
phorylation promotes the anti-inflammatory properties of SNHht
and that this pathway is operational in the intestine.
MSK1/2 is Essential for the Anti-inflammatory
Properties of SNHht
The mitogen and stress-activated protein kinase (MSK) iso-
forms, MSK1 and MSK2, are activated downstream of p38 and
ERK1/2 in vivo and phosphorylate CREB, triggering the rapid
transcription of CREB target genes (Ananieva et al., 2008). We
stimulated BMDMs differentiated from WT and Msk1/2/ mice
with SNHht. Immunoblot analysis of pS133-CREB1 and
pT581-MSK1 revealed that SNHht phosphorylates MSK1 and
that SNHht-mediated CREB phosphorylation requires MSK1/2
(Figure 7A). The stimulation of WT and Msk1/2/ BMDMs with
SNHht for 1 hr confirmed that the induction of CREB target genes
(Il10, Fosb, andEgr3) is highly dependent onMSK1/2, contrary to
the induction of Il6, Tnf, or Cd40 (Figures 7B and S6). As ex-
pected, Msk1/2/ BMDMs produced less IL-10 but more IL-6
and TNFa in response to 10 hr stimulation with SNHht. The
Msk1/2 deletion led to a strong reduction of both IL-10/IL-6
and IL-10/TNFa ratios, such that they were indistinguishable
from the ratios induced by whole H. hepaticus or Pam3
(Figure 7C). Together, these data indicate that both MSK1/2
and CREB are required for the anti-inflammatory properties
of SNHht.
DISCUSSION
The intestine is home to billions of bacteria, and this complex
ecosystem plays an important role in health and disease. It is
well appreciated that microbial induction of IL-10 in the intestine
is a non-redundant feature of tolerance to themicrobiota, but the
molecular dialog between host and microbe that determines
tolerance and immunity remains elusive. Here, we show that
H. hepaticus strain ATCC51449 produces a large polysaccharide
that shapes themacrophage response. This polysaccharide trig-
gers a high IL-10/IL-6 ratio compared to canonical TLR2 ago-
nists and selectively activates the transcription factor CREB
that, in turn, induces a panel of anti-inflammatory and repair me-
diators in the intestine.
H. hepaticus can be considered as a pathosymbiont based on
its ability to live in harmony with its murine host in the presence of
an IL-10 response, and its potential to drive IL-23-driven intesti-
nal inflammation in IL-10 deficiency. The bacterial-sensing path-
ways that mediate these distinct responses are poorly under-
stood. Our current understanding derives from in vitro studies
in BMDMs showing that the activation of ERK inhibits the induc-
tion of IL-12 p40 by H. hepaticus (Tomczak et al., 2006).
Figure 7. MSK1/2 Is Essential to the Anti-inflammatory Properties of SNHht
(A) Western blot showing the phosphorylation of CREB1 S133 and MSK1 T581 and the total CREB1 and MSK1 protein amounts in WT and Msk1/2/ BMDMs
after 30 min stimulation with TSBt, SNHht, Pam3, or LPS UP.
(B) mRNA levels of Il10, Fosb, and Egr3 genes in BMDMs from WT or Msk1/2/ mice after 1 hr stimulation.
(C) Induction of IL-10, IL-6, and TNFa; IL-10/IL-6; and IL-10/TNFa protein ratios in BMDMs from WT or Msk1/2/ mice after 10 hr stimulation.
One of three independent experiments. Two-way ANOVA and Sidak’s and/or Tukey’s multiple comparisons tests, p < 0.05. Mean ± SD. See also Figure S6.
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Moreover, epithelial cell lines transfected with human TLR2
could recognize the whole bacteria (Mandell et al., 2004). A
key role for the adaptor MyD88 has been shown in vivo in the in-
flammatory response to H. hepaticus in IL-10 deficiency, but the
upstream sensors were not identified (Asquith et al., 2010; Bou-
lard et al., 2010). Our results show that H. hepaticus produces a
polysaccharide that induces a specific CREB-dependent anti-in-
flammatory and repair gene signature in macrophages via the
TLR2 pathway. CREB targets include Il10 as well as transcription
factors that downregulate NF-kBand T cell activation, and genes
involved in tissue repair. The transcription factor CREB is known
to limit pro-inflammatory signaling downstream of TLRs and
stimulate Il-10 transcription (Cohen, 2014;Wen et al., 2010). Pre-
vious studies have shown TLR-mediated activation of the CREB
pathway. For example, LPS stimulation of BMDMs induced anti-
inflammatory genes in an MSK/CREB-dependent manner
(Ananieva et al., 2008; Darragh et al., 2010). Similarly, the
TLR2/DECTIN-1 ligand zymosan and TLR2/4-signaling extracts
from Schistosoma mansoni cercariae were able to activate
CREB in BMDMs and induce various CREB target genes that
are associated with a ‘‘regulatory’’ macrophage phenotype or
cell metabolism, respectively (Elcombe et al., 2013; Sanin
et al., 2015). Here, we identified a bacterial factor able to activate
a CREB-dependent anti-inflammatory program both in vitro and
in vivo, suggesting that the CREB pathway might play a crucial
role in host-microbiota mutualism.
IL-10 itself inhibits the production of pro-inflammatory cyto-
kines in macrophages through Jak–STAT3 activation (Moore
et al., 2001; Murray, 2006); however, we found that the early in-
duction of CREB targets by SNHht is independent of IL-10R
signaling but rather relies on MSK1/2 kinase activity. Activated
by p38 and ERK1/2, MSK1/2 phosphorylates multiple sub-
strates, including CREB, ATF1, and Histone H3, and predomi-
nantly has anti-inflammatory roles (Reyskens and Arthur,
2016). Here, the deletion of MSK1/2 has a larger effect on
SNHht-induced anti-inflammatory ratios compared to the loss
of CREBS133 phosphorylation. This suggests that MSK1/2 acti-
vates both CREB-dependent and independent anti-inflamma-
tory pathways in response to SNHht, potentially involving His-
tone H3-mediated epigenetic changes. As SNHht also induces
this CREB/MSK-dependent immunomodulatory program in in-
testinal tissue in vivo, it is likely that it contributes to mutualistic
relationships in the H. hepaticus-infected gut. Further studies
are required to test this hypothesis.
IL-10 was previously shown to be critical for macrophage con-
ditioning within the intestinal tissue, but IL-10 production by
macrophages per se is not sufficient to explain their homeostatic
activity (Shouval et al., 2014; Zigmond et al., 2014). The ability of
SNHht to induce a CREB-driven anti-inflammatory response that
is IL-10 independentmay reveal additional checkpoints that con-
trol the macrophage inflammatory response in the intestine.
H. hepaticus also promotes IL-10-producing regulatory T cells
(Kullberg et al., 2002) raising the possibility that SNHht-condi-
tioned macrophages promote this response.
By contrast with SNHht, the canonical TLR2 ligand Pam3
induced a broad NF-kB-dependent pro-inflammatory response
in BMDMs. Microbe-induced TLR2 signaling promotes both
pro- and anti-inflammatory responses (Nemati et al., 2017; Oli-
veira-Nascimento et al., 2012). However, it is not known whether
this is a consequence of the structural features of particular li-
gands or whether it reflects the activities of additional sensors
and receptors. CLRs, such as DECTIN-1 and DC-SIGN, have
been shown to collaborate with TLRs to select specific re-
sponses to infectious agents (Ferwerda et al., 2008; Gantner
et al., 2003). Here, we have ruled out the involvement of several
CLRs and the common downstream CLR-signaling protein
CARD9 in IL-10 induction by SNHht. Progress in this area is
hampered by the often complex bacterial cell wall structures.
Despite considerable effort, we were not able to analyze the
structure and composition of the polysaccharide produced by
H. hepaticus. The genome of H. hepaticus ATCC51449 does
not contain a canonical polysaccharide biosynthesis operon,
but many polysaccharide glycosyltransferase and LPS synthesis
genes (Lombard et al., 2014). The LPS from H. hepaticus
CCUG33637 was described as a low molecular weight molecule
(Hynes et al., 2004), making a similar molecule an unlikely candi-
date. However, we cannot rule out that the highmolecular weight
polysaccharide produced byH. hepaticus ATCC51449 also con-
tains lipid moieties. Additional analyses are required to decipher
the structure and the conservation of this molecule across
species. One approach is to sequence different strains of
H. hepaticus to determine whether this activity is unique to a
particular strain or a more general feature. In preliminary studies,
we found that H. hepaticus strain ATCC51448 did not possess
the same immunomodulatory activity as strain ATCC51449
(data not shown). Comparative analyses of the sequences of
these two stains could help identify gene candidates associated
with polysaccharide biosynthesis. However, these studies are in
their infancy as only strain ATCC51449 has been fully sequenced
(Suerbaum et al., 2003).
The host response to H. hepaticus shares some features with
that elicited by Bacteroides fragilis, a member of the human gut
microbiota that can induce abscesses and bacteraemia (Wexler,
2007). Challenge of II-10/ mice with B. fragilis also leads
to higher inflammation and mortality compared to WT mice,
emphasizing the important role of IL-10 in host-microbe interac-
tions (Cohen-Poradosu et al., 2011). Interestingly,B. fragilis poly-
saccharide A (PSA, strain NCTC 9343) was able to limit colitis in
mice (Mazmanian et al., 2008). PSA activates TLR2 on plasma-
cytoid dendritic cells and regulatory T cells to induce immune
regulatory functions, including IL-10 production and suppres-
sion of Th17 responses (Dasgupta et al., 2014; Round et al.,
2011). PSA is a capsular zwitterionic polysaccharide (ZPS).
ZPSs contain positive and negative repeating charges that are
crucial to their immunomodulatory activity (Surana and Kasper,
2012). Recently, Lozupone et al. performed a genomic screen
for human gut bacteria encoding ZPSs but did not identify Heli-
cobacter species (Neff et al., 2016). Furthermore, in the genome
ofH. hepaticus strain ATCC51449, we did not find any significant
BLAST hits to ZPS biosynthesis genes from B. fragilis, suggest-
ing that these two bacteria produce different types of polysac-
charide or employ different mechanisms of production. These
results, together with our own, illustrate that the host utilizes
TLR pathways not only to initiate host defense, but to bolster im-
mune regulatory pathways that promote intestinal homeostasis
(Rakoff-Nahoum et al., 2004).
In summary, our studies show that H. hepaticus produces
an immunomodulatory polysaccharide that conditions the
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macrophage response via a TLR2/CREB-driven anti-inflamma-
tory pathway. A better understanding of the molecular crosstalk
between host cells and commensal bacteria is of major impor-
tance to decipher mutualistic mechanisms. Enhancement of
these could helpmaintain homeostasis following disruptive chal-
lenges such as antibiotic treatment, enteric infection, stress, and
food allergy, as well as aid restoration of a balanced dialog in the
face of chronic inflammation. Identification of immunomodula-
tory ligands produced by commensals will require an integrated
approach combining immunology, microbiology, bioinformatics,
and biochemistry. This field of investigation is challenging but
highly valuable as it could ultimately provide new preventive
and therapeutic strategies for infectious and inflammatory
diseases.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-IL-10 APC antibody (clone JES5-16E3) eBioscience clone JES5-16E3, RRID:
AB_469502
Mouse IgG2k isotype control (Rat, clone A95-1) BD Pharmingen clone A95-1, Cat# 556924
Anti-mTLR2-IgG (clone C9A12) monoclonal
antibody
InvivoGen clone C9A12, Cat#
mabg-mtlr2
Mouse IgG2A isotype control (clone 20102) Biotechne (R&D systems) clone 20102, MAB003
CD11b (clone M1/70) BioLegend, London, UK clone M1/70
RRID: AB_312791
CD11c (clone N418) BioLegend, London, UK clone N418
RRID: AB_313771
MHCII (clone M5/114.15.2) BioLegend, London, UK clone M5/114.15.2,
RRID: AB_313321
CD64 (clone X54-5/7.1) BioLegend, London, UK clone X54-5/7.1
RRID:AB_10612740
CD45 (clone 30-F11) BD Biosciences, Oxford, UK clone 30-F11
Total ERK1/2 Cell Signaling Technology #4695
pT202/Y204-ERK1/2 (clone D13.14.4E) Cell Signaling Technology clone D13.14.4E, #4370
Total p38 Cell Signaling Technology #9212
pT180/Y182-p38 (clone 3D7) Cell Signaling Technology clone 3D7, #9215
pS133-CREB1 (clone 87G3) Cell Signaling Technology clone 87G3, #9198
pT581-MSK1 Cell Signaling Technology #9595
Total CREB1 (clone E306) Abcam clone E306, #ab32515
Total MSK1 (#AF2518) R&D systems Accession #O75582
Bacterial and Virus Strains
Helicobacter hepaticus strain ATCC51449 ATCC ATCC51449
Helicobacter hepaticus strain ATCC51448 ATCC ATCC51448
Biological Samples
Pam2CSK4 InvivoGen Cat# tlrl-pm2s-1
Pam3CSK4 InvivoGen Cat# tlrl-pms
FSL-1 InvivoGen Cat# tlrl-fsl
Zymosan, cell wall from Saccharomyces cerevisiae InvivoGen Cat# tlrl-zyn
LM-MS, Lipomannan from Mycobacterium
smegmatis
InvivoGen Cat# tlrl-lmms1
LPS ultrapure from E. coli O111:B4 InvivoGen Cat# tlrl-3pelps
LPS standard from E. coli O55:B5 InvivoGen Cat# tlrl-b5lps
Chemicals, Peptides, and Recombinant Proteins
Sodium metaperiodate Alfa Aesar, Heysham, UK CAS# 7790-28-5
Concanavalin A from Canavalia ensiformis (Jack
bean), agarose conjugate
Sigma L7555
Lectin from Arachis hypogaea (peanut)
agarose conjugate
Sigma L2507
Lectin from Lens culinaris (lentil), agarose
conjugate
Sigma L4018
U0126 Merck Chemicals 662005-1MG
p38 MAP Kinase Inhibitor VIII, EO 1428 Merck Chemicals 506163-5MG
NF-kB Activation Inhibitor II, JSH-23 Merck Chemicals 481408-5MG
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
(5Z)-7-Oxozeaenol Calbiochem 499610
sp600125 Sigma S5567
Critical Commercial Assays
DuoSet ELISA kits R&D Systems Europe – Biotechne N/A
High-Capacity cDNA Reverse Transcriptase Applied Biosystems, Life Technologies,
Paisley, UK
N/A
PrecisionFAST mastermix Primerdesign N/A
TaqMan gene expression assays Life Technologies N/A
RNeasy Mini kit (for tissue and microarray) QIAGEN, Manchester, UK N/A
Quick-RNA MiniPrep kit (for primary cell cultures) Zymo Research, Cambridge Bioscience, UK N/A
Illumina MouseWG-6-V2 microarrays Illumina N/A
Deposited Data
Microarray data ArrayExpress E-MTAB-5780
Experimental Models: Organisms/Strains
Mus musculus, NCBI Taxonomy ID:10090,
C57BL/6
Charles River RRID:IMSR_JAX:000664
Oligonucleotides
Hprt TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm01545399_m1
Il10 TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm00439614_m1
Il6 TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm00446190_m1
Tnf TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm00443258_m1
Fosb TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm00500401_m1
Egr3 TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm00516979_m1
Rcan1 TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm01213406_m1
Cd40 TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm00441891_m1
Icam1 TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm00516023_m1
Ccl5 TaqMan Gene Expression Assays for mouse,
Life Technologies
Mm01302427_m1
Software and Algorithms
FlowJo software Tree Star, Ashland, OR N/A
GraphPad Prism 7.02 GraphPad Software, CA N/A
Lumi R/Bioconductor N/A
LIMMA R/Bioconductor N/A
Molecular Signatures Database (MSigDB, C3,
motif gene sets)
http://software.broadinstitute.org/gsea/
msigdb/collections.jsp
N/A
Transfac identifier http://www.gene-regulation.com/pub/
databases.html
N/A
runGO.py from the Computational Genomics
Analysis Toolkit (CGAT)
https://github.com/CGATOxford/cgat N/A
Other
Fortessa BD Biosciences N/A
ViiA 7 Real-Time PCR System Life Technologies N/A
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Fiona
Powrie (fiona.powrie@kennedy.ox.ac.uk).
EXPERIMENTAL MODEL DETAILS
Mice
Wild-type C57BL/6 mice were bred and maintained under specific pathogen-free (SPF) conditions in accredited animal facilities at
the University of Oxford. Experiments were conducted in accordance with the UK Scientific Procedures Act (1986) under a Project
License (PPL) authorized by the UK Home Office. Mice were routinely screened and negative for Helicobacter spp. and other known
intestinal pathogens and were over 6 week-old when experiments were started. Both males and females were used. Co-housed lit-
termates of same sex were randomly assigned to experimental groups with the same number of males and females in the different
experimental groups. Experimental groups were then kept in separated cages during treatment with TSB/SNHht or infection with
H. hepaticus. H. hepaticus infection was performed by oral administration. Colonization with live H. hepaticus was controlled by
qRT-PCR performed on total tissue mRNA using probes for the gene cdtB. 250 mL of 1mg/ml brefeldin A (from Penicillium Breffel-
dianu, Sigma-Aldrich Co) was injected intra-peritoneally 12 h before harvest for FACS staining experiments.
Bacterial Culture
The Gram-negative mouse pathobiont Helicobacter hepaticus strain ATCC51449 was grown in tryptone soya broth (TSB, Fisher)
supplemented with 10% Fetal Calf Serum (FCS) and Skirrow Campylobacter supplements (Oxoid) in microaerophilic conditions
(1%–3% oxygen). After 24 h at 37C under agitation, the culture broth was centrifuged at 4500 rpm for 50 min and filtrated through
a 0.2 mm filter. The supernatants were collected and stored at 20C.
Culture of Mouse Bone-Marrow Derived Macrophages
Bone-marrow cells from SPF WT or knockout C57BL/6 mice (any sex) were cultured for 8 days in complete RPMI with 50 ng/ml mu-
rineM-CSF (Peprotech) and seeded at 100,000 cells on 96-well tissue culture plates overnight before stimulation. After differentiation
with M-CSF, 90%–95% of bone-marrow derives macrophages (BMDMs) expressed CD11b and CD64, 15%MHCII and 5% CD11c
by flow cytometry. Bone-marrow from knock-out and knock-in mice was provided by the collaborators listed in the Acknowledg-
ments section.
METHODS DETAILS
Isolation of Leukocytes from the Lamina Propria
For lamina propria leukocyte (LPL) isolation, the colon and the caecum of C57BL/6mice were opened longitudinally, washed, and cut
into pieces. Pieces were washed twice in RPMI-1640 medium supplemented with 5% fetal bovine serum (FBS) and 5mM EDTA at
37C with shaking to remove epithelial cells. Tissue was then digested at 37C for 1 h in a shaking incubator with 1 mg/ml type VIII
collagenase (Sigma-Aldrich, Gillingham, UK) and 40 mg/ml DNase I in RPMI supplemented with 5%FBS. Cells were then layered on a
40/80% Percoll gradient, centrifuged, and the interface was recovered.
Flow Cytometry and Intracellular Staining
For surface staining, cells were first incubated with Fc block (anti-CD16/CD32, eBioscience) to minimize nonspecific antibody bind-
ing, and then stained for 20 min in phosphate-buffered saline / 0.1% bovine serum albumin / 5 mMEDTA buffer with a fixable viability
dye and a combination of the following antibodies: CD11b (M1/70), CD11c (N418), MHCII (M5/114.15.2), CD64 (X54-5/7.1) (all from
BioLegend, London, UK) and CD45 (30-F11) (fromBDBiosciences, Oxford, UK). Following surface staining, cells were fixedwith PFA
2%, permeabilized with saponin 0.05% and incubated with an anti-IL-10 APC antibody (clone JES5-16E3, eBioscience) at dilution
1/50 for 20min. All cells were analyzed on a Fortessa (BDBiosciences) and analysis was performed using FlowJo software (Tree Star,
Ashland, OR).
Treatment of H. hepaticus Culture Supernatant
SNHht was obtained by treating the filtered culture supernatant with 50 mg/ml DNase I (Roche) and RNase A (Roche) for 2 hours at
37C, thenwith 40 mg/ml proteinaseK (Sigma) overnight at 56C, and finally with heat for 2 h in awater bath at 95C. Protein and nucleic
acid digestions were controlled using Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and agarose gels,
respectively. To obtain SNHht > 30kDa andSNHht < 30kDa fractions, SNHht was concentrated on Vivaspin 20MWCO30 000 columns
(GE healthcare Biosciences) for 30min at 3000 rpm. Sodiummetaperiodate oxidation was performed at 1 mMNaIO4 98% (Alfa Aesar,
Heysham,UK) in 0.1M sodiumacetate pH 5.5 for 6 h at RT in foil, followed by dialysis against distilled water for 2 days at 4C to remove
NaIO4 traces using Pur-A-Lyzer
TM Maxi 3500 tubes (Sigma). Lectin agarose conjugates (Concanavalin A from Canavalia ensiformis
(ConA), lectins from Arachis hypogaea (peanut - PNA) and Lens culinaris (lentil - LcH) (Sigma) were added to SNHht or TSBt to deplete
the polysaccharide and incubated for 5 h on a wheel at RT, followed by 30 min rest and 10 min centrifugation at 13 000 rpm.
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Ethanol Precipitation of the Crude Polysaccharide
CPHht was precipitated from SNHht by the addition of 4 volumes of ice cold ethanol and incubated at20C overnight. Crude poly-
saccharide fractions from TSBt (CPTSBt) were extracted using the same method as a control. Precipitated polysaccharides were
recovered by centrifugation at 5000 rpm for 10 min, the pelleted precipitate was re-suspended in water and dialysed against 5 L
of water for 48 h with two water changes to remove residual ethanol before being dried in a freeze dryer.
Stimulation of BMDMs
BMDM cultures were infected with 0.5 OD H. hepaticus in RPMI (from frozen stock of live culture, Multiplicity Of Infection = 10),
H. hepaticus culture supernatant, TSBt control medium or different TLR ligands (Pam2CSK4 (85 ng/ml), Pam3CSK4 (75 ng/ml),
FSL-1 (100 ng/ml), Zymosan, cell wall from Saccharomyces cerevisiae (100 ng/ml); LM-MS, Lipomannan fromMycobacterium smeg-
matis (1 ng/ml), LPS ultrapure from E. coliO111:B4 (20 ng/ml), LPS standard from E. coliO55:B5 (1 ng/ml) - all from InvivoGen) for 3 h
at 37C in a humidified incubator with 5% CO2. Blocking antibodies specifically inhibiting TLR2 signaling (Anti-mTLR2-IgG (C9A12)
monoclonal antibody, InvivoGen) or a mouse IgG2A isotype control (Biotechne) were added at 0.3 mg/ml 1 h prior stimulation. Kinase
inhibitors were used at 10 mM (UO126 (MEK1/2), JSH-23 (NFkb), Merck Chemicals; Sp600125 (JNK), Sigma), 5 mM (EO 1428 (p38),
Merck Chemicals) or 1 mM (5z-7-oxozeanol (Tak1), Calbiochem) and added 30 min prior stimulation. Stimulation assays were per-
formed in duplicates and repeated three or more times.
ELISA Assay
For measurement of secreted cytokines using Mouse IL-10, IL-6 and TNF-a DuoSet ELISA kits (R&D Systems Europe – Biotechne),
culture supernatants were collected and stored at 20C.
RNA Extraction
BMDMs or lamina propria cells were lysed in RLT buffer (QIAGEN, Manchester, UK) or Zymo Lysis Buffer (Zymo Research,
Cambridge Bioscience, UK) and stored at 80C. RNA was isolated from snap-frozen samples using the RNeasy Mini kit (QIAGEN,
Manchester, UK) or the Quick-RNA MiniPrep kit (Zymo Research, Cambridge Bioscience, UK) according to the manufacturer’s in-
structions, including an on-column DNase I digestion step. For microarray analysis on BMDMs, the RNeasy Mini kit (QIAGEN,
Manchester, UK) was used.
Quantitative RT-PCR
Complementary DNA synthesis was performed using High-Capacity cDNA Reverse Transcriptase (Applied Biosystems, Life Tech-
nologies, Paisley, UK). Quantitative PCR reactions for the candidate genes were performed using PrecisionFAST mastermix (Primer-
design) and TaqMan gene expression assays (Life Technologies). Complementary DNA samples were analyzed in duplicate using
ViiA 7 Real-Time PCR System (Life Technologies), and gene expression levels for each sample were normalized to HPRT. Mean rela-
tive gene expression was determined, and the differences were calculated using the 2DC(t) method. Primer pairs and probes were as
follows: TaqMan Gene Expression Assays for mouse Hprt (Mm01545399_m1), Il10 (Mm00439614_m1), Il6 (Mm00446190_m1), Tnf
(Mm00443258_m1), Fosb (Mm00500401_m1), Egr3 (Mm00516979_m1), Rcan1 (Mm01213406_m1), Cd40 (Mm00441891_m1),
Icam1 (Mm00516023_m1) and Ccl5 (Mm01302427_m1).
Immunoblot Analysis
Cells were washed with PBS and lysed using Laemmli sample loading buffer (2% SDS, 10% glycerol, 50 mM DTT, 0.002% brom-
phenol blue and 62.5 mM Tris HCl, pH 6.8). Equal amounts of proteins were resolved by SDS–PAGE using NuPAGE Novex Bis-
Tris Gels (Thermo Fisher Scientific) and analyzed with antibodies against total ERK1/2, pT202/Y204-ERK1/2 (D13.14.4E), total
p38, pT180/Y182-p38 (3D7), pS133-CREB1 (87G3), pT581-MSK1 (all from Cell Signaling Technology), total CREB1 (E306,
ab32515, Abcam) and total MSK1 (R&D systems) followed by detection with horseradish peroxidase (HRP)–conjugated secondary
antibodies and the chemiluminescent substrate solution ECL (GE Healthcare)
QUANTIFICATION AND STATISTICAL ANALYSIS
Microarray Analysis of Stimulated BMDMs
Expression profiles of M-CSF differentiated BMDMs stimulated for 3 h with either TSBt (1/10), SNHht (1/10) or Pam3CSK4 (75 ng/ml)
were obtained using Illumina MouseWG-6-V2microarrays (n = 5 for each condition). Probes were used for downstream processing if
they were expressed significantly above background (detection P value < 0.05) in at least three samples. This resulted in the analysis
of 16, 692 probes (out of a total of 45, 289). Array signal intensities were background adjusted, transformed using the variance-sta-
bilizing transformation and quantile normalized using Lumi from R/Bioconductor. Differential expression analysis was performed for
each condition contrast using the empirical Bayes method in LIMMA (Linear Models for Microarray and RNA-seq Data from
R/Bioconductor). Significancewas defined as a Benjamini-Hochberg adjusted P value < 0.05 and fold change > 2. The union of signif-
icantly different probes was visualized in a heatmap and probes were clustered into distinct sets using k-means clustering (k = 4) as
implemented in R (k means function in R3.1.0). Sequencing data was generated by the High-Throughput Genomics Group at the
Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z).
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Transcription Factor Motif Enrichment Analysis
We tested for the enrichment of transcription factor motifs among genes that were observed to be specifically upregulated in either
SNHht or Pam3CSK4 conditions. Transcription factor motif annotations were downloaded from the Molecular Signatures Database
(MSigDB, C3, motif gene sets at http://software.broadinstitute.org/gsea/msigdb/collections.jsp). These comprise sets of genes that
are predicted to be bound by a given transcription factor based on the presence of a conserved motif in their promoter or 30 UTR. As
we were interested in motifs that could readily be attributed to a particular transcription factor, we filtered the database to retain only
those motifs that had a designated Transfac (http://www.gene-regulation.com/pub/databases.html) identifier. This resulted in the
analysis of 499 motifs (from a total of 836 in the full database). Enrichment analysis was performed using the hypergeometric test
implemented in runGO.py from the Computational Genomics Analysis Toolkit (CGAT; https://github.com/CGATOxford/cgat) and
gene sets were considered significant at an empirically derived adjusted p value < 0.05.
Statistical Analysis
Statistical tests were performed using GraphPad Prism 7.02 and specified in figure legends. Differences were considered to be sig-
nificant when p < 0.05. All bar charts represent means ± SD.
DATA AND SOFTWARE AVAILABILITY
Accession Numbers/Data Availability Statement
The accession number for the microarray data reported in this paper is ArrayExpress: E-MTAB-5780.
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